Reynoso Jamie L.'s Form 4 filing
Clover Health Investments, Corp. (CLOV) · filed Oct 7, 2025
- Accession no.
- 0001801170-25-000240
- Filed
- Oct 7, 2025
- Trade date
- Oct 3-7, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $5.33K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reynoso Jamie L.CIK 0001839066 | Officer (CEO, Medicare Advantage) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2025 | Class A Common Stock | FTax withholdingDisposed | −8,706 | $2.59 | −$22,548.54 | 3,045,184 | Direct | |
| Oct 7, 2025 | Class A Common Stock | SSaleDisposed | −2,012 | $2.65 | −$5,331.8 | 3,043,172 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.